MAT2B and liver cancer: Over-expression of MAT2B V1 or V2 increases the cytoplasmic content of HuR and induces the expression of downstream targets of HuR, namely cyclin D1 and cyclin A. Hence one of the mechanisms by which MAT2B variants promote survival of liver cancer cells is by modulating HuR-mediated interactions with factors implicated in cell growth.